This Review provides an overview of the main targetable surface proteins in prostate cancer, defined as the surfaceome, discussing the mechanisms of action and efficacy of currently available drugs targeting surface proteins, as well as future perspectives of integrating these treatments into prostate-cancer management.
- Cristina Boixareu
- Tarek Taha
- Himisha Beltran